iPower Fiscal 2022 Revenue Grows 47%, Here Are The Details
iPower Inc. (NASDAQ: IPW), released its financial results for its fiscal fourth quarter and full year ended June 30, 2022, revealing fiscal 2022 revenue of $79.4 million, a 47% increase year-over-year.
Canopy Growth Exits Cannabis Retail Business In Canada, Here’s Why
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) is divesting its retail business across Canada, including the stores operating under the Tweed and Tokyo Smoke retail banners.
Psychedelics Capital Markets: Silo Pharma’s IPO, $5M Common Stock Offering
Developmental-stage biopharma company Silo Pharma Inc. (NASDAQ: SILO) announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at $5.00 per share, to begin trading on NASDAQ on Tuesday, September 27, 2022 under trading symbol “SILO.”
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
In parallel with working towards discovering and advancing therapeutic psychedelics, biopharma companies are continuously protecting their findings.
Ten Multistate Cannabis Companies Owe $500M To The IRS, Says A New Report
An analysis of financial filings by Green Market Report showed that ten publicly traded multistate cannabis companies are carrying over $500 million in federal tax debts.
Canopy Growth Announces Divestiture of Canadian Retail Operations
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) announced today that the Company has entered into agreements to divest its retail business
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
GAINERS:
Biomind Labs (OTC:BMNDF) shares closed up 11.10% at $1.10
Marijuana Stock Movers For September 27, 2022
GAINERS:
HEXO (NASDAQ:HEXO) shares closed up 5.57% at $0.18
Cybin Acquires Exclusive License To Mindset Pharma’s Tryptamine Compounds Family
Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc.